Unraveling a Novel Cystic Fibrosis Anti-PA Intervention Therapy
Reference number | |
Coordinator | Immun System I.M.S. Aktiebolag |
Funding from Vinnova | SEK 3 250 000 |
Project duration | November 2012 - July 2015 |
Status | Completed |
Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Unraveling a Novel Cystic Fibrosis Anti-PA Intervention Therapy
Reference number | 2012-02717 |
Coordinator | Immun System I.M.S. Aktiebolag |
Funding from Vinnova | SEK 3 250 000 |
Project duration | November 2012 - July 2015 |
Status | Completed |
Last updated 25 November 2019
Reference number 2012-02717